Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 1:32 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1441–1464 of 3,978 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Pathophysiology Clear all

Conditions: Endothelial Dysfunction, Biochemical Markers
Interventions: Electronic Cigarette Aerosol; Drug
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 35 Years
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Multiple Sclerosis
Interventions: PACR (Plasticity-based, Adaptive, Computerized Cognitive Remediation); Other
Lead sponsor: Stony Brook University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 136 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2013
U.S. locations: 1
States / cities: Stony Brook, New York

Conditions: Delirium
Interventions: Dexmedetomidine, Lorazepam; Drug
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2016
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Multiple Organ Failure, Septic Shock, Severe Sepsis
Interventions: Best Practice, early metabolic resuscitation; Other · Dietary Supplement
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Cognitive Impairments, Schizotypal Personality Disorder
Interventions: DAR-0100A, Placebo; Drug
Lead sponsor: Larry J. Siever; Other
Eligibility: 18 Years to 60 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: New York, New York

Conditions: Heart Failure With Reduced Ejection Fraction, Endothelial Dysfunction
Interventions: TVS, Sham TVS; Device
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years to 80 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Normal Subjects, Fecal Incontinence
Interventions: Fecobionics; Device
Lead sponsor: The California Medical Innovations Institute, Inc.; Other
Eligibility: 18 Years to 100 Years
Enrollment: 155 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 2
States / cities: San Diego, California • Augusta, Georgia

Conditions: Alzheimer Disease, Mild Cognitive Impairment
Interventions: 2-hydroxybenzylamine acetate, Placebo; Drug · Other
Lead sponsor: MTI Biotech Inc; Industry
Eligibility: 55 Years to 85 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Mild Cognitive Impairment, Alzheimer Dementia
Interventions: CpG1018, Placebo; Drug
Lead sponsor: NYU Langone Health; Other
Eligibility: 60 Years to 85 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Non-alcoholic Fatty Liver Disease
Interventions: Efimosfermin alfa; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 5
States / cities: Rialto, California • Miami Lakes, Florida • Tampa, Florida + 2 more

Conditions: CTEPH
Interventions: Not listed
Lead sponsor: Intermountain Health Care, Inc.; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Murray, Utah

Conditions: Cognitive Impairment, Schizophrenia
Interventions: Cognitive Rehabilitation Therapy (CRT) + Skill Training (SDG), Individual Computer Based Cognitive Rehabilitation (ICBCR) and Skills Training (SDG), Skills Group (SDG); Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2009
U.S. locations: 1
States / cities: West Haven, Connecticut

Conditions: Parkinson Disease, Freezing of Gait
Interventions: Multiple Deep Brain Stimulation (DBS) Conditions, Moving Overground in a Virtual Environment (MOVE), Cleveland Clinic Stair Ambulation and Functional Evaluation of Gait (SAFE-Gait); Other · Behavioral
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Myelodysplastic Syndrome, Effects of Chemotherapy, Mild Cognitive Impairment, Multiple Myeloma, Non-hodgkin Lymphoma, Chronic Lymphocytic Leukemia, Acute Lymphoid Leukemia, Chronic Myeloid Leukemia, Acute Myeloid Leukemia
Interventions: Not listed
Lead sponsor: University of Nebraska; Other
Eligibility: 19 Years to 80 Years
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Acute Pulmonary Embolism, Thromboembolism, Emboli, Pulmonary, Thrombosis, Thrombus; Embolism, Embolism, Cardiovascular Diseases, Vascular Diseases
Interventions: Symphony Thrombectomy System; Device
Lead sponsor: Imperative Care, Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 19
States / cities: Huntsville, Alabama • Los Angeles, California • Jacksonville, Florida + 15 more

Conditions: Mild Cognitive Impairment
Interventions: NewGam 10% IVIG, Placebo; Drug · Other
Lead sponsor: Sutter Health; Other
Eligibility: 50 Years to 84 Years
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2020
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Ventilator Induced Diaphragm Dysfunction
Interventions: Lungpacer Diaphragm Pacing Therapy; Device
Lead sponsor: Lungpacer Medical Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 223 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 22
States / cities: Stanford, California • Aurora, Colorado • Gainesville, Florida + 17 more

Conditions: Multiple Sclerosis, Mild Cognitive Impairment, Cancer
Interventions: CT-100 DiNaMo, Care-as-Usual; Other
Lead sponsor: Click Therapeutics, Inc.; Industry
Eligibility: 22 Years to 75 Years
Enrollment: 114 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 1
States / cities: New York, New York

Conditions: Endothelial Function, Diabetes Mellitus, Hypertension
Interventions: carvedilol, metoprolol extended release; Drug
Lead sponsor: State University of New York - Downstate Medical Center; Other
Eligibility: 18 Years to 80 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Brooklyn, New York

Conditions: Traumatic Brain Injury, Fatigue, Cognitive Impairment, COVID-19
Interventions: Somatropin; Drug
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: 18 Years to 70 Years
Enrollment: 72 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Blood Cancer, Lymphoma, Leukemia, Myeloma
Interventions: Music Therapy/MT, Therapist-Attention Music Education/TAME Control; Other
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 7
States / cities: Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more

Conditions: Erectile Dysfunction
Interventions: avanafil; Drug
Lead sponsor: VIVUS LLC; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 712 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 40
States / cities: Birmingham, Alabama • Homewood, Alabama • Tucson, Arizona + 34 more

Conditions: Executive Dysfunction
Interventions: Unstuck and On Target: Preschool; Behavioral
Lead sponsor: Children's National Research Institute; Other
Eligibility: 3 Years to 6 Years
Enrollment: 63 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Silver Spring, Maryland

Conditions: Post Traumatic Stress Disorder
Interventions: Repetitive Transcranial Magnetic Stimulation (rTMS), Cognitive Processing Therapy, Repetitive Transcranial Magnet Stimulation (rTMS); Device · Behavioral
Lead sponsor: The University of Texas at Dallas; Other
Eligibility: 18 Years to 60 Years
Enrollment: 103 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2016
U.S. locations: 1
States / cities: Dallas, Texas

Search by objective public record fields.

Acute Effects of E-Cigarette Aerosol Inhalation

Computerized Cognitive Exercise Training Treatment for Adults With Multiple Sclerosis

MENDS Study: Trial in Ventilated ICU Patients Comparing an Alpha2 Agonist Versus a Gamma Aminobutyric Acid (GABA)-Agonist to Determine Delirium Rates, Efficacy of Sedation, Analgesia and Discharge Cognitive Status

Early Metabolic Resuscitation for Septic Shock

Clinical Testing of a D1 Agonist for Cognitive Enhancement in Schizotypal Personality Disorder

Effect of Transcutaneous Vagal Stimulation (TVS) on Endothelial Function and Arterial Stiffness in HFrEF

Trial to Evaluate Fecobionics in Fecal Incontinence (FI) (NORMAL and ABNORMAL-FI)

2-Hydroxybenzylamine (2-HOBA) Study in Early Alzheimer's Patients

Innate Immunity Stimulation Via TLR9 in Early AD

A Study of Efimosfermin Alfa in Adults With Hepatic Impairment

Biological Sex and CTEPH-related RV Dysfunction and Recovery (BIOSPHeRe)

Cognitive Rehabilitation in Schizophrenia

Decoding the Neural Mechanisms Underlying Postural Instability and Gait Dysfunction in Parkinson's Disease

Electrophysiological Biomarkers of Chemotherapy-related Cognitive Impairment and Recovery

SYMPHONY-PE Study for Treatment of Pulmonary Embolism

Study of Intravenous Immunoglobulin in Amnestic Mild Cognitive Impairment

A Protocol Comparing Temporary Transvenous Diaphragm Pacing to Standard of Care for Weaning From Mechanical Ventilation

Effects of a CT-100 DiNaMo Component on Cognitive Functioning and Mood Symptoms

Coreg CR, Blood Vessel Stiffness and Blood Vessel Function

Brain and Gut Plasticity in Mild TBI or Post-acute COVID Syndrome Following Growth Hormone Therapy

A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties

Long-Term Safety and Efficacy Study of Avanafil in Men With Erectile Dysfunction

Development and Pilot Testing of a Novel Preschool Executive Function Curriculum

Novel Treatment of Emotional Dysfunction in Post Traumatic Stress Disorder (PTSD)